I formerly worked at
https://corista.com, dealing specifically with integrations with AI pathology algorithm vendors like
https://www.qritive.com and
https://visiopharm.com. (Note: we dealt specifically with microscopy rather than radiology.)
I really think we were doing things the “right way” before I left: providing AI analyses from various vendors as overlays for slides, and being able to pre-flag slides with obvious cases of cancer or other infection. (These analyses typically being custom algorithms provided by vendors through APIs we collaborate on, not LLM output.)
With things like this simply built into an existing, established pathology platform, I’m pretty confident a team of 4-5 pathologists could do the work of 6-8, with better quality output, similar to how Copilot and other tooling speeds us up as developers. At $300-400k/yr/doctor, that’s considerable savings (and the opportunity to allocate more doctors in specialties that aren’t easily automated).
However, for lots of reasons, it seems the market doesn’t necessarily agree with me on the value potential of this approach in this field (which can certainly be a self-fulfilling prophecy).